11 – 20 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
(
- Contribution to journal › Letter
-
Mark
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
(
- Contribution to journal › Scientific review
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
(
- Contribution to journal › Article
-
Mark
Allergen immunotherapy for allergic asthma : The future seems bright
(
- Contribution to journal › Article
-
Mark
Eosinophils—from cradle to grave
(
- Contribution to journal › Article
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
2023) In Allergy: European Journal of Allergy and Clinical Immunology(
- Contribution to journal › Article
-
Mark
Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics
(
- Contribution to journal › Article
-
Mark
Pre-asthma : a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
(
- Contribution to journal › Article
-
Mark
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses : EAACI task force on eicosanoids consensus report in times of COVID-19
(
- Contribution to journal › Article